Many biologics, including blockbusters like Epogen/Procrit, are nearing patent expiration, and generics manufacturers, including Sicor (acquired by Teva), Barr Laboratories, and Ivax Corporation, are hoping to market generic biologics.
June 08, 2026
June 04, 2026
April 28, 2026
April 15, 2026
March 06, 2026
January 28, 2026
November 13, 2025